DOCSLIB.ORG

Journal of Virology

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Journal of Virology JOURNAL OF VIROLOGY VOLUME 36 0 NUMBER 3 0 DECEMBER 1980 EDITORIAL BOARD Robert R. Wagner, Editor-in-Chief (1982) University of Virginia School ofMedicine, Charlottesville Dwight L. Anderson, Editor (1983) Harold S. Ginsberg, Editor (1984) School of Dentistry, Columbia University University ofMinnesota, New York, N. Y. Minneapolis David T. Denhardt, Editor (1982) Edward M. Scolnick, Editor (1982) University of Western Ontario National Cancer Institute London, Ontario, Canada Bethesda, Md. David Baltimore (1981) Nancy Hopkins (1980) Fred Rapp (1981) Amiya K. Baaerjee (1982) Calderon Howe (1982) Dan S. Ray (1980) jeaneth 1. Berns (1982) Alice S. Huang (1981) M. E. Reicn (1982) IH. L Bishop (1982) D. C. Kelly (1982) Bernard E. Reilly (1980) DavlW9otstein (1982) Tlomas J. Kelly, Jr. (1982) Willham S. Robinson (1980) Michael A. Bratt (1980) George Khoury (1981) Benard Ro (1982) Dennis T. Brown (1981) Jonathan A. King (1981) Roland R. Rueckert (1982) Ahmad 1. Bukhari (1981) David W. Kingsbury (1982) Norman P. Salman (1981) Purnell Choppin (1980) Lloyd M. Kozloff (1982) Joseph Sambook (1982) John M. Coffin (1980) Robert M. Knig (1980) Priscila A. Schaffer (1981) Richard W. Compans (1982) Robert A. L i 1981) Sondra S ger (1980) Geoffrey M. Cooper (1981) Richard A. Lerner (1981) Phlp A. Sharp (1982) Nicbolas R. Cozzarelli (1980) Myron Levine (1982) Aaron J. Shatkln (1982) Clive Dickson (1981) Tomas Lindahl (1981) Saul J. Silverstein (1982) Walter Doerfier (1980) David M. Livingston (1980) Lee D. Simon (1981) Harrison Echols (1981) Ronald B. Luftig (1981) Kai Simn (1981) Elvera Ebrenfeld (1980) Robert MartiDn (1981) Alan E. Smith (1980) Robert N. Eisenaa (1982) Lois K. Miller (1982) Patricia G. Spear (1981) Suzanoe U. Emerson (1980) Robert C. Miller (1980) F. William Studier (1981) Lynn Enquist (1981) Gisela Mosig (1982) Lawrence S. Sturnan (1982) Erw* . Fleissner (1980) Bernard Moss (1980) Donald F. Summers (1982) S. Jaze Flint (1981) Joseph S. Pagano (1982) William C. Summers (1980) Robert M. Friedman (1982) J. Thomas Parsons (1980) John M. Taylor (1981) Larry M. Gold (1982) Ulf G. Petterson (1980) Howard M. Temin (1982) Hidesaburo Hanafusa (1980) Lennart Philipson (1981) David C. Ward (1980) William S. Hayward (1981) Peter G. W. Plagemann (1980) Ernest Winocour (1982) John J. Holland (1981) Craig R. Pringle (1980) Julius Youngner (1982) Giseila Pollock, Acting Managing Editor Susan Birch, Production Editor 1913 I St., NW, Washington, DC 20006 EX OFFICIO Albert Balows, President (1980-1981) Frederick C. Neidhardt, President-Elect (1980-1981) J. Mebsen Joseph, Secretary Brinton M. Miller, Treasurer The Journal of Virology (ISSN 0022-538X), a publication of Second-class postage paid at Washington, DC 20006, and at the American Society for Microbiology, 1913 1 St., NW, Wash- additional mailing offices. ington, DC 20006, is devoted to the dissemination offundamental Made in the U.S.A. knowledge concerning viruses of bacteria, plants, and animals. Copyright i 1980, American Society for Microbiology. Inves ators are invited to submit reports of original research in All Rights Reserved. all areas of basic virology, including biochemistry, biophysics, genetics, immunology, morphology, and physiology. Instructions to Authors are published in the January issue each year. The The code at the top of the first page ofan article in thisjournal Journal is issued monthly, four volumes per year. The nonmem- indicates the copyright owner's consent that copies of the article ber subscription price is $90 per year, single copies are $8. The may be made for personal use, or for personal use of specific member subscription price is $21 per year. Correspondence clients. This consent is given on the condition, however, that the relating to subscriptions, reprints, defective copies, availability of copier pay the stated per-copy fee through the Copyright Clear- back issues, lost or late proofs, disposition of submitted manu- ance Center, Inc., P.O. Box 765, Schenectady, New York 12301, and general editorial matters should be directed to the for copying beyond that permitted by Sections 107 and 108 of ASS Publications Office, 1913 I St., NW, Washington, DC the U.S. Copyright Law. This consent does not extend to other 20006 (area 202 833-9680). kinds of copying, such as copying for general distribution, for advertising or promotional purposes, for creating new collective ai* : idbm 119*lkA ,-1 E 11IrAff,fl ( I fo works, or for resale. Author Index AAwine, James C., 701 Fujinaga, Kei, 639 Lodish, Harvey F., 719 :jBErson, Steven M., 676 Gerlich, Wolfram H., 787 Marion, Patricia L., 787 Bastow, K. F., 746 Grandgenett, Duane P., 889 Mason, William S., 829 Battula, Narayana, 709 Groner, Bernd, 734 Mbuy, Gustave N., 837 Bearzotti-Le Berre, Monique, Minson, A. C., 746 652 Mitchell, R. L., 805 Bellamy, A. R., 894 Halbert, Donald N., 860 Bernard, Jacqueline, 652 Hanafusa, Hidesaburo, 676 Nayak, Debi P., 847 Boettiger, David, 883 Harris, Tixnothy J. R., 659 Neel, Benjamin G., 676 Dennis 775 Harvey, J. D., 894 Brown, T., Hayward, William S., 676 Peters, Gordon G., 692 Buetti, Elena, 734 Heilman, Carole A., 878 Pignatti, Pier F., 816 Howley, Peter M., 878 Pons, Marcel W., 837 4ai, Enzo, 816 Hu, James, 692 Porter, Mary, 719 Chowdhury, Kamal, 878 Huang, Alice S., 756 Clark, Daniel R., 766 Hulen, Christian, 633 Ralph, S. J., 894 ,~i~,Fulmer, 872 Hynes, Nancy E., 734 Rao, Donald D., 756 Cowra, Jon H., 796 Raskas, Heschel J., 860 Cooper, Geoffrey M., 684 Rentier-Delrue, Francoise, 878 Courtney, Richard J., 665 Israel, Mark A., 878 Robinson, William S., 787 Rosenberg, Naomi E., 766 lxy, G., 746 Jenkins, Nancy A., 684 De, arun K., 847 Sawada, Yukiharu, 639 de Kinkelin, P., 652 Kawka, Douglas, 872 Schiff, Ron D., 889 Demsey, Anthony, 872 Khoury, George, 701 Seal, Geeta, 829 Diggelmann, Heidi, 734 Krzyzek, R. A., 805 Spector, David J., 860 Dorsch-Hasler, Karoline, 837 Steimer, Kathelyn S., 883 Summers, Jesse, 829 Labedan, Bernard, 633 Eberle, R., 665 Lambert, Dennis M., 837 Takemoto, Kenneth K., 878 Erwin, Christine, 775 Lau, A. F., 805 Todaro, George J., 709 Law, Ming-Fan, 878 Faras, A. J., 805 Lazzarini, Robert A., 796 Wildy, P., 746 Feitelson, Mark A., 787 Legault-Demare, Jean, 633 Witte, Owen N., 766 ACKNOWLEDGMENT The following have served as invited special reviewers for the Journal during 1980, and their help is greatly appreciated. Stuart Aaronson Mike Fried Philip McAllister Josef Aloni Robert J. Galo D. James McCorquodale James Alwine E. Peter Geiduschek Joseph Melnick Christian Anfinsen John Gemn Trudy G. Morrison Ralph B. Arlinghaus Raymond Gilden K. Mullini J. Thomas August Robert Goldberg Frederick A. Murphy Richard Axel Neil Goldman John R. Murphy John P. Bader Michael Gottesman Daniel Nathans Carrado Baglioni T. Graf Paul E. Neiman L. Andrew Ball Angus F. Graham Robert Newarth Claudio Bascilico Duane Grandgenett Abner L. Notkins Robert Bassin Allan Granoff Robert Nowinski Karen Beemon Maurice Green Stephen O'Brien Thomas Benjamin Beverly Griffin Paul O'Donnell Peter B. Berget Neal B. Groman Michael B. A. Oldstone Alan Bernstein Peter Gruss Peter M. Palese S Edward Birkenmeier Ashley Haase Amon Panet 0 J. Michael Bishop Gordon Hager Takis Papas Klaus Bister Stephen C. Harrison Arthur Pardee David Boettinger Janet Hartley Wade Parks Michael Botchan William Haseltine Ira Pastan Sidney Breese Ian H. Holmes Janice Pero Sean Brennan Jerard Horowitz Jacques Perrault Doris Bucher Peter Howley Sidney Pestka Clarence A. Buller S. Hughes William A. Petri, Jr. Janet Butel Anthony Hunter Ralf F. Petterson R. Callahan James Ihle Paula Pitha Allan M. Campbell Mark Israel Robert Pollack Robert Cardiff Gilbert Jay Alan R. Price Esther Chang George Johnson Carol Prives Robert Chanock Richard Johnson Al Rabson Craig Cohen Wolfgang K. Joklik Ulf Rapp Marc Collett David Kabat James A. Rawles Donald L. Court Paul J. Kaesberg John Reeve John Dahlberg Robert Kamen Daniel Rifldin James E. Darnell William Kamen Richard Roberts Vittorio Defendi C. Yong Kang Betty Jo Robertson E. DeHarvin Albert Kapikian Harriett Robinson Albert DeLeu Albert Kaplan John K. Rose Melvin DePamphilis Kathleen Kennedy Jeff Rosen Michael Dexter S. I. T. Kennedy Naomi Rosenberg Ravi Dhar Saul Kit Ellen Rothenberg Heidi Diggelmann Edward Kuff Wallace P. Rowe Giampiero di Mayorca Ching-Juh Lai Sandra Ruscetti Dino Dina Michael Lai M. Sarngadharan Joseph Dipaolo Lloyd Law Andreas S. Scheid Gideon Dreyfus Paul Lebowitz Charles Scherr Edward J. Dubovi Peter Lengyel Milton Schlesinger Peter H. Duesberg Arnold J. Levine Jeffrey Schlom Walter Eckhart A. Lindberg Manfred Schweiger John Elder Maxine Linial Bartholomew M. Sefton Ray Erickson Paul S. Lovett Roland Seif Mary K. Estes Rex E. Lovrien Peter Shank Leonard Evans Douglas Lowy Joel B. Sheffield Hung Fan Roderick MacLeod Thomas Shenk Anthony J. Faras Manley Mandel Charles Sherr Bernard Fields Jack Maniloff Thomas Shih Peter Fischinger James Manley Robert W. Simpson William Folk Stuart Marcus Maxine Singej C. Fred Fox G. Steven Martin Anna Skalka < Heinz Fraenkel-Conrat Malcolm A. Martin D. Peter Snustad Richard M. Franklin Heather D. Mayor Mitchell Sogin William A. Stark Leland Velicer Sue Wickner Jesse Summer Anne K. Vidaver Evelyn Wilkin Raquel Sussman Peter K. Vogt S. G. Wilkinson Waclaw Szybalski Volker Vogt Mark Willingham Peter Tegtmeyer Don Walker Gary A. Wilson Satvir Tevethia Duard L. Walker Eckard Wimmer Robert E. Thach L. H. Wang Owen Witte George Todaro Huber R. Warner Robert Yang Thomas A. Trautner Robert E. Webster Wen Yang Stephen Tronick Robert A. Weinberg Hamish Young Philip Tsichlis I. B. Weinstein Howard A. Young George Vande Woude Peter Weisbeek Jack J. Zakowski James L. Van Etten Sherman Weissman Paul Zamecnik Harold Varmus Heiner Westphal Harold Zur Hausen AUTHOR INDEX VOLUME 36 AI-Shaiiwari Abdul J. N., 120 Diggelmann, Heidi, 734 Hawke, Mary, 506 Alwine, James, 143 di Mayorca, Giampiero, 480 Hayward, William S., 676 Alwine, James C., 701 Dimock, Kenneth, 361 Heilman, Carole A., 395, 878 Anderson, Dwight L., 236 Dixon, Richard A.
Load more

Recommended publications
  • ASM Journals Eliminate Impact Factor Information from Journal Websites
    ASM Journals Eliminate Impact Factor Information from Journal Websites The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Casadevall, A., S. Bertuzzi, M. J. Buchmeier, R. J. Davis, H. Drake, F. C. Fang, J. Gilbert, et al. 2016. “ASM Journals Eliminate Impact Factor Information from Journal Websites.” mSphere 1 (4): e00184-16. doi:10.1128/mSphere.00184-16. http:// dx.doi.org/10.1128/mSphere.00184-16. Published Version doi:10.1128/mSphere.00184-16 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:27822275 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA EDITORIAL crossmark ASM Journals Eliminate Impact Factor Information from Journal Websites Arturo Casadevall,a Editor in Chief, mBio®, Stefano Bertuzzi,b Chief Executive Officer, ASM, Michael J. Buchmeier,c Editor in Chief, Microbiology and Molecular Biology Reviews®, Roger J. Davis,d Editor in Chief, Molecular and Cellular Biology®, Harold Drake,e Editor in Chief, Applied and Environmental Microbiology®, Ferric C. Fang,f Editor in Chief, Infection and Immunity®, Jack Gilbert,g Editor in Chief, mSystems™, Barbara M. Goldman,b Director, Journals, ASM, Michael J. Imperiale,h Editor in Chief, mSphere™, Philip Matsumura,i Editor, Genome Announcements™, Alexander J. McAdam,j Editor in Chief, Journal of Clinical Microbiology®, Marcela F. Pasetti,k Editor in Chief, Clinical and Vaccine Immunology®, Rozanne M.
    [Show full text]
  • The Role of Hepatitis C Virus in Hepatocellular Carcinoma U
    Viruses in cancer cell plasticity: the role of hepatitis C virus in hepatocellular carcinoma U. Hibner, D. Gregoire To cite this version: U. Hibner, D. Gregoire. Viruses in cancer cell plasticity: the role of hepatitis C virus in hepato- cellular carcinoma. Contemporary Oncology, Termedia Publishing House, 2015, 19 (1A), pp.A62–7. 10.5114/wo.2014.47132. hal-02187396 HAL Id: hal-02187396 https://hal.archives-ouvertes.fr/hal-02187396 Submitted on 2 Jun 2021 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution - NonCommercial - ShareAlike| 4.0 International License Review Viruses are considered as causative agents of a significant proportion of human cancers. While the very Viruses in cancer cell plasticity: stringent criteria used for their clas- sification probably lead to an under- estimation, only six human viruses the role of hepatitis C virus are currently classified as oncogenic. In this review we give a brief histor- in hepatocellular carcinoma ical account of the discovery of on- cogenic viruses and then analyse the mechanisms underlying the infectious causes of cancer. We discuss viral strategies that evolved to ensure vi- Urszula Hibner1,2,3, Damien Grégoire1,2,3 rus propagation and spread can alter cellular homeostasis in a way that increases the probability of oncogen- 1Institut de Génétique Moléculaire de Montpellier, CNRS, UMR 5535, Montpellier, France ic transformation and acquisition of 2Université Montpellier 2, Montpellier, France stem cell phenotype.
    [Show full text]
  • Clinical Molecular Genetics in the Uk C.1975–C.2000
    CLINICAL MOLECULAR GENETICS IN THE UK c.1975–c.2000 The transcript of a Witness Seminar held by the History of Modern Biomedicine Research Group, Queen Mary, University of London, on 5 February 2013 Edited by E M Jones and E M Tansey Volume 48 2014 ©The Trustee of the Wellcome Trust, London, 2014 First published by Queen Mary, University of London, 2014 The History of Modern Biomedicine Research Group is funded by the Wellcome Trust, which is a registered charity, no. 210183. ISBN 978 0 90223 888 6 All volumes are freely available online at www.history.qmul.ac.uk/research/modbiomed/ wellcome_witnesses/ Please cite as: Jones E M, Tansey E M. (eds) (2014) Clinical Molecular Genetics in the UK c.1975–c.2000. Wellcome Witnesses to Contemporary Medicine, vol. 48. London: Queen Mary, University of London. CONTENTS What is a Witness Seminar? v Acknowledgements E M Tansey and E M Jones vii Illustrations and credits ix Abbreviations xi Ancillary guides xiii Introduction Professor Bob Williamson xv Transcript Edited by E M Jones and E M Tansey 1 Appendix 1 Photograph, with key, of delegates attending The Molecular Biology of Thalassaemia conference in Kolimbari, Crete, 1978 88 Appendix 2 Extracts from the University of Leiden postgraduate course Restriction Fragment Length Polymorphisms and Human Genetics, 1982 91 Appendix 3 Archival material of the Clinical Molecular Genetics Society 95 Biographical notes 101 References 113 Index 131 Witness Seminars: Meetings and Publications 143 WHAT IS A WITNESS SEMINAR? The Witness Seminar is a specialized form of oral history, where several individuals associated with a particular set of circumstances or events are invited to meet together to discuss, debate, and agree or disagree about their memories.
    [Show full text]
  • Sensitive Detection of Oncoviruses Integrated Into a Comprehensive Tumor Immuno-Genomics Platform #3788
    Sensitive detection of oncoviruses integrated into a comprehensive tumor immuno-genomics platform #3788 Gábor Bartha, Robin Li, Shujun Luo, John West, Richard Chen Personalis, Inc. | 1330 O’Brien Dr., Menlo Park, CA 94025 Contact: [email protected] Introduction Results Mixed Oncoviral Cell Lines We obtained 22 cell lines from ATCC containing HPV16, HPV18, HPV45, HPV68, HBV, EBV, KSHV, HTLV1 and HTLV2 in which the oncoviruses HPV, HBV, HCV and EBV viruses are causally EBV Cell Lines were known to be in the tumors from which the cell lines were created. In the ATCC samples we detected 23 out of 23 oncoviruses expected in linked to over 11% of cancers worldwide while both the DNA and RNA. We detected all the different types of oncoviruses that we targeted except for HCV because it wasn’t in any sample. In all KSHV, HTLV and MCV are linked to an additional To test the ability of the platform to detect oncoviruses, we identified a set of 11 EBV cell lines from but one case the signals were strong. 1%. As use of immunotherapy expands to a Coriell in which EBV was used as a transformant. We detected EBV in all the Coriell cell lines in both broader variety of cancers, it is important to DNA and RNA indicating strong sensitivity of the platform. Wide dynamic ranGe suggests quantification Detected in DNA Detected in RNA Virus Tissue Notes understand how these oncoviruses may be may be possible as well. In the DNA and RNA there were no detections of any other oncovirus EBV EBV EBV HodGkin’s lymphoma Per ATCC : “The cells are EBNA positive" indicating high specificity.
    [Show full text]
  • Nucleotide Sequences in Mouse DNA and RNA Specific for Moloney Sarcoma Virus
    Proc. Nati. Acad. Sci. USA Vol. 73, No. 10, pp. 3705-3709, October 1976 Microbiology Nucleotide sequences in mouse DNA and RNA specific for Moloney sarcoma virus (murine sarcoma virus/RNA tumor virus/nucleic acid hybridization/gene evolution/sarcoma-specific nucleotide sequence) ARTHUR E. FRANKEL AND PETER J. FISCHINGER Laboratory of Viral Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20014 Communicated by Howard M. Temin, July 12,1976 ABSTRACT Complementary DNA (cDNA) synthesized (3). Laboratory strains of oncoviruses do contain information by Moloney murine sarcoma virus (M-MSV) was separated into that is different from the spontaneously released oncovirus of two parts, the first, termed MSV-specific cDNA, composed of the species Of nucleotide sequences found only in M-MSV viral RNA, and the (6, 7). these, the sarcomagenic oncoviruses gen- second, termed MSV-MuLV common cDNA, composed of nu- erally contain both a set of nucleotide sequences shared with cleotide sequences that were found in both M-MSV and murine leukosis-leukemia viruses, and another set of sequences that are leukemia virus (MuLV) viral RNAs. RNA complementary to the dissimilar from those of other oncoviruses of the species (6-10). MSV-specific cDNA was not found in several other MSV iso- Complementary DNA (cDNA) can be transcribed from sar- lates, nor in ecotropic MuLV, mouse mammary tumor virus, or coma virus RNA by the viral endogenous DNA polymerase. several murine xenotropic oncoviruses. Cellular DNA of several The cDNA represents both the "shared" and the species was examined for the presence of nucleotide sequences "specific" complementary to MSV-specific cDNA. Cells transformed by moieties of the sarcoma virus genome.
    [Show full text]
  • Cancer Patients Have a Higher Risk Regarding COVID-19–And Vice Versa?
    pharmaceuticals Opinion Cancer Patients Have a Higher Risk Regarding COVID-19–and Vice Versa? Franz Geisslinger, Angelika M. Vollmar and Karin Bartel * Pharmaceutical Biology, Department Pharmacy, Ludwig-Maximilians-University of Munich, 81377 Munich, Germany; [email protected] (F.G.); [email protected] (A.M.V.) * Correspondence: [email protected] Received: 29 May 2020; Accepted: 3 July 2020; Published: 6 July 2020 Abstract: The world is currently suffering from a pandemic which has claimed the lives of over 230,000 people to date. The responsible virus is called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and causes the coronavirus disease 2019 (COVID-19), which is mainly characterized by fever, cough and shortness of breath. In severe cases, the disease can lead to respiratory distress syndrome and septic shock, which are mostly fatal for the patient. The severity of disease progression was hypothesized to be related to an overshooting immune response and was correlated with age and comorbidities, including cancer. A lot of research has lately been focused on the pathogenesis and acute consequences of COVID-19. However, the possibility of long-term consequences caused by viral infections which has been shown for other viruses are not to be neglected. In this regard, this opinion discusses the interplay of SARS-CoV-2 infection and cancer with special focus on the inflammatory immune response and tissue damage caused by infection. We summarize the available literature on COVID-19 suggesting an increased risk for severe disease progression in cancer patients, and we discuss the possibility that SARS-CoV-2 could contribute to cancer development.
    [Show full text]
  • Holmes Washington 0250E 22
    ©Copyright 2020 Daniel Holmes Identification of Targetable Vulnerabilities During Latent KSHV Infection Daniel Holmes A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Washington 2020 Reading Committee: Michael Lagunoff, Chair Adam Philip Geballe Jason G Smith Program Authorized to Offer Degree: Department of Microbiology University of Washington Abstract Identification of Targetable Vulnerabilities During Latent KSHV Infection Daniel Holmes Chair of the Supervisory Committee: Professor Michael Lagunoff Department of Microbiology Viruses are defined as obligate intracellular parasites that require host processes to repli- cate. Latent virus life cycles are no exception to this definition, as viruses are still reliant on host machinery for continued proliferation and maintenance of viral genomes, even in the absence of lytic replication. In this thesis, I used essentiality screening to identify host factors on which Kaposi's Sarcoma Associated Herpesvirus (KSHV) relies for the proliferation and survival of latently infected cells. KSHV is the etiological agent of Kaposi's Sarcoma (KS), an endothelial cell-based tumor where more than 90% of the endothelial cells in the tumor are latently infected with KSHV. While traditional therapies for herpesviruses target lytic replication, the prevalence of latency in KS necessitates exploration of options for intervening in this stage of the viral life cycle. I performed CRISPR/Cas9 screening using lentiviral vec- tors encoding a library of single guide RNAs (sgRNAs) targeting every protein coding gene in the human genome. I compared mock infected and KSHV infected endothelial cells eight days post infection to identify genes essential to latent KSHV infection.
    [Show full text]
  • Human Papillomaviruses and Epstein–Barr Virus Interactions in Colorectal Cancer: a Brief Review
    pathogens Review Human Papillomaviruses and Epstein–Barr Virus Interactions in Colorectal Cancer: A Brief Review 1,2, 1,2, 1, 1,2, Queenie Fernandes y, Ishita Gupta y, Semir Vranic * and Ala-Eddin Al Moustafa * 1 College of Medicine, QU Health, Qatar University, Doha 2713, Qatar; [email protected] (Q.F.); [email protected] (I.G.) 2 Biomedical Research Centre, Qatar University, Doha 2713, Qatar * Correspondence: [email protected] (S.V.); [email protected] (A.-E.A.M.); Tel.:+974-4403-7873 (S.V.); +974-4403-7817 (A.-E.A.M.) Both authors contributed equally to this review. y Received: 9 March 2020; Accepted: 7 April 2020; Published: 20 April 2020 Abstract: Human papillomaviruses (HPVs) and the Epstein–Barr virus (EBV) are the most common oncoviruses, contributing to approximately 10%–15% of all malignancies. Oncoproteins of high-risk HPVs (E5 and E6/E7), as well as EBV (LMP1, LMP2A and EBNA1), play a principal role in the onset and progression of several human carcinomas, including head and neck, cervical and colorectal. Oncoproteins of high-risk HPVs and EBV can cooperate to initiate and/or enhance epithelial-mesenchymal transition (EMT) events, which represents one of the hallmarks of cancer progression and metastasis. Although the role of these oncoviruses in several cancers is well established, their role in the pathogenesis of colorectal cancer is still nascent. This review presents an overview of the most recent advances related to the presence and role of high-risk HPVs and EBV in colorectal cancer, with an emphasis on their cooperation in colorectal carcinogenesis.
    [Show full text]
  • Historischer Abriss
    Historischer Abriss 1970 Geschichte der Zellbiologie im Überblick Entdeckung der reversen Transkription durch H. (Kapitel 1.1) Temin und D. Baitimare 17. Jahrhundert 1972 Bezeichnung der porenartigen Strukturen des Fluid-mosaic-Modell der Zellmembran (S. Singer Korks als "Zellen" durch R. Hooke und G. Nicholson) Identifizierung von Amöben und Bakterien im 1973 durch A. van Leeuwenhoek Mikroskop Erstes rekombinantes DNA-Molekül 1838 1975 Entdeckung, dass Pflanzen aus Zellen aufgebaut Erzeugung von monoklonalen Antikörpern durch sind (M. Schleiden) C. Milstein und G. Köhler 1839 1976 Beschreibung der Zelle als strukturelle Einheit des Entdeckung des v-src-Onkogens durch H. Varmus Lebens durch T. Schwann und M. Bishop Um 1850 Aufklärung des Rearrangements von Immunglobu­ Mendel-Vererbungsgesetze lingenen durch S. Tonegawa 1855 1977 Erkenntnis, dass Zellen nur durch Teilung aus an­ Entdeckung der rezeptorvermittelten Endozytose deren Zellen entstehen (R . Virchow) durch M. Brown und ]. Goldstein 1911 1980 Tumorinduktion durch Viren (P. Rous) Isolierung von G-Proteinen durch A. Gilman 1945 1982 Erstes elektronenmikroskopisches Bild einer intak­ Prionenhypothese von S. Prusiner ten Zelle durch K. R. Porter, A. Claude und E. F. DNA-Sequenzierungsmethoden nach Sanger und Fullam Gilbert 1951 1983 Erste In-vitro-Kultur von humanen Zellen durch Erfindung der Polymerasekettenreaktionsmethode G. Gey (HeLa) durch K. Mullis 1953 1989 Modell der DNA-Doppelhelix durch]. Watson und Erzeugung von Knockout-Mäusen durch M. Cap­ F. Crick pechi 1961 1996 Entschlüsselung des genetischen Kodes durch M. Verwendung DNA-Mikroarrays zur Analyse der Nirenberg Genexpression Operon Modell von F. ]acob und ]. Monod Chemiosmotische Theorie der oxidativen Phospho­ 2000 rylierung von P. Mitchell Vollständige Sequenz des humanen Genoms Ganten I Ruckpaul (Hrsg.) Grundlagen der Molekularen Medizin, 2.
    [Show full text]
  • B I O T E C H I N T H E S U N S H I N E S T A
    BIOTECH IN THE SUNSHINE STATE December 2009 American Society for Biochemistry and Molecular Biology ASBMB2011 SPECIAL SYMPOSIA CALL FOR PROPOSALS Partner with the American Society for Biochemistry and Molecular Biology to bring your community together! ASBMB Special Symposia provides you, as a specialized researcher, a unique opportunity to present cutting-edge science mixed with active networking opportunities in an intimate setting. How We’re Different: Format: Majority of talks selected from abstracts, invited speakers, 2-4 days in length Attendee: 60- 200 attendees, including investigators, industry professionals, graduate and postdoctoral students Venues: Unique locations near natural resources that enable time for outdoor recreation and networking opportunities Funding: ASBMB provides initial funding as well as staff support! Learn More About Special Symposia and Proposal Submission Guidelines at www.asbmb.org/meetings Proposals Due March 1, 2010 ATodayFullPageAd_2011_Proposal Submission2.indd 1 11/23/2009 10:50:10 AM contents DECEMBER 2009 On the cover: ASBMB hopes that your holidays are filled with society news lots of serotonin. 2 Letters to the Editor IMAGE: REBECCA HANNA 20 4 President’s Message 7 Washington Update 8 News from the Hill 11 Member Spotlight 12 Retrospective: Mahlon Hoagland (1921-2009) A retrospective 15 Retrospective: on Mahlon Charles Tanford (1921-2009) Hoagland. 12 2010 annual meeting 18 Nobel Laureate Claims the 2010 Herbert Tabor Lectureship 19 Kinase Researcher Named Recipient of FASEB Award special interest 20 Centerpieces: Burnham Institute Touches Down in Orlando departments 26 Education and Training Regulating 30 Minority Affairs transcriptional activity. 32 BioBits 32 34 Career Insights 36 Lipid News resources Scientific Meeting Calendar podcast summary online only Check out the latest ASBMB podcast, in which Journal of Biological Chemistry Associate Editor James N.
    [Show full text]
  • Can a Virus Cause Cancer: a Look Into the History and Significance of Oncoviruses
    UC Berkeley Berkeley Scientific Journal Title Can A Virus Cause Cancer: A Look Into The History And Significance Of Oncoviruses Permalink https://escholarship.org/uc/item/6c57612p Journal Berkeley Scientific Journal, 14(1) ISSN 1097-0967 Author Rwazavian, Niema Publication Date 2011 DOI 10.5070/BS3141007638 Peer reviewed|Undergraduate eScholarship.org Powered by the California Digital Library University of California CA N A VIRU S CA U S E CA NCER ? A LOOK IN T O T HE HI st ORY A ND SIGNIFIC A NCE OF ONCO V IRU S E S Niema Rwazavian The IMPORTANC E OF ONCOVIRUS E S (van Epps 2005). Although many in the scientific Cancer, a disease caused by unregulated cell community were unconvinced of the role of viruses in growth, is often attributed to chemical carcinogens cancer, research on the subject nevertheless continued. (e.g. tobacco), hormonal imbalances (e.g. high levels of In 1933, Richard Shope discovered the first mammalian estrogen), or genetics (e.g. breast cancer susceptibility oncovirus, cottontail rabbit papillomavirus (CRPV), gene 1). While cancer can originate from any number which could infect cottontail rabbits, and in 1936, John of sources, many people fail to recognize another Bittner discovered the mouse mammary tumor virus important etiology: oncoviruses, or cancer-causing (MMTV), which could be transmitted from mothers to pups via breast milk (Javier and Butle 2008). By the 1960s, with the additional “…despite limited awareness, oncoviruses are discovery of the murine leukemia BSJ virus (MLV) in mice and the SV40 nevertheless important because they represent virus in rhesus monkeys, researchers over 17% of the global cancer burden.” began to acknowledge the possibility that viruses could be linked to human cancers as well.
    [Show full text]
  • Editors' Statement on Considerations of Biodefence and Biosecurity
    EDITORIAL Editors’ statement on considerations of biodefence and biosecurity The threat of bioterrorism requires active consideration by scientists. On 9 January 2003, the US National Academy of Sciences held a discussion on the balance between scientific openness and security. The next day, a group of editors met to discuss the issues with specific reference to the scientific publication process. The following statement has emerged from that meeting. The principles dis- cussed will be considered and followed through by Nature Medicine The process of scientific publication, is a view, shared by nearly all, that there is FOURTH: We recognize that on occasions through which new findings are reviewed information that, although we cannot an editor may conclude that the potential for quality and then presented to the rest now capture it with lists or definitions, harm of publication outweighs the poten- of the scientific community and the pub- presents enough risk of use by terrorists tial societal benefits. Under such circum- lic, is a vital element in our national life. that it should not be published. How and stances, the paper should be modified, or New discoveries reported in research pa- by what processes it might be identified not be published. Scientific information is pers have helped improve the human con- will continue to challenge us, because – as also communicated by other means: semi- dition in myriad ways: protecting public all present acknowledged — it is also true nars, meetings, electronic posting, etc. health, multiplying agricultural yields, that open publication brings benefits not Journals and scientific societies can play fostering technological development and only to public health but also in efforts to an important role in encouraging investi- economic growth, and enhancing global combat terrorism.
    [Show full text]